{{Rsnum
|rsid=2894207
|Gene=WASF5P
|Chromosome=6
|position=31295974
|Orientation=plus
|GMAF=0.2089
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.3 | 28.3 | 66.4
| HCB | 3.8 | 33.1 | 63.2
| JPT | 0.9 | 26.1 | 73.0
| YRI | 1.4 | 22.6 | 76.0
| ASW | 7.0 | 26.3 | 66.7
| CHB | 3.8 | 33.1 | 63.2
| CHD | 2.8 | 36.4 | 60.7
| GIH | 20.8 | 44.6 | 34.7
| LWK | 8.3 | 48.1 | 43.5
| MEX | 0.0 | 41.4 | 58.6
| MKK | 11.7 | 55.2 | 33.1
| TSI | 10.9 | 38.6 | 50.5
| HapMapRevision=28
}}

{{PMID Auto GWAS
|PMID=20512145
|Trait=Nasopharyngeal carcinoma
|Title=A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.
|RiskAllele=
|Pval=3E-33
|OR=1.64
|ORtxt=[1.52-1.75]
}}

{{omim
|id=607107
|rsnum=2894207
}}

{{PMID Auto
|PMID=19107206
|Title=Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study.
|OA=1
}}

{{PMID Auto
|PMID=21214922
|Title=Psoriasis prediction from genome-wide SNP profiles.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}